Claim your profile

Make the profile of
Misogi Labs yours.

Take over your company profile and every software page tied to it. Write your own descriptions, add your own material, and keep it current — from a single admin panel.

What's on Life Sciences Digital today

Here's what visitors see about you right now.

Your profile on Life Sciences Digital — and the pages for each of your products — were compiled from publicly available materials. We take care to get it right, but nobody knows Misogi Labs the way you do, and some of what visitors read today may be out of date or wrong. Claiming the profile lets you correct it directly.

Company description

Coincidence Labs is an AI-powered copilot platform purpose-built for pharmaceutical research and development. The company deploys purpose-built AI agents that automate the ingestion and structuring of data from patents, scientific literature, clinical trials, and internal sources, enabling biopharma teams to test hypotheses faster, uncover insights across fragmented data, and align decisions across functions. By transforming unstructured R&D data into defensible, traceable intelligence, Coincidence Labs helps drug discovery teams spend less time buried in documents and more time creating value.

The platform serves a broad range of life sciences stakeholders, including pharmaceutical companies, contract research organizations (CROs), IP advisors, and strategy consulting firms. Its AI agents are designed to address the full spectrum of R&D challenges, from Target Product Profile (TPP) definition through to IND-enabling studies and portfolio decision-making.

Core Platform Capabilities

  • Agentic Research Automation: AI agents automate research-heavy workflows, ingesting and structuring data from patents, literature, clinical data, on-premises data, chemistry databases, toxicity databases, and integrated tools, enabling experts to surface insights at scale.
  • Patent Intelligence at Scale: Transforms unstructured patents into actionable intelligence by surfacing novel compounds, competitive signals, and freedom-to-operate (FTO) risks. The platform can expand Markush claims, screen structural overlap across patent families, and cross-link findings to formulations and method-of-use claims, cutting weeks of costly patent analysis into minutes.
  • Molecular Data Management: Enables teams to interact with molecular data in a traceable and collaborative environment. The platform embeds molecular insights into workflows that align chemists, DMPK experts, toxicologists, and program leaders around defensible decisions.
  • AI-Powered Target Product Profile (TPP) Builder: A guided, multi-step tool that helps teams define disease area, indication, and patient population, structuring strategic program parameters from the outset.
  • Molecule Extraction and Analysis: Automatically extracts molecules from documents and data sources, providing key properties including absorption metrics (aqueous solubility, PAMPA permeability, Caco-2 permeability), distribution parameters (blood-brain barrier penetration, plasma protein binding), metabolism data (hepatic clearance), and toxicity indicators (hERG liability).

Key Use Cases by Stakeholder

  • For Pharma Teams: Accelerates progress from target identification to the clinic by compressing patent and literature review timelines, surfacing known liabilities and competitive overlaps early, and enabling confident stage-gate and portfolio decisions with traceable, evidence-backed insights.
  • For CROs: Supports faster delivery of research outputs by automating document-intensive analysis tasks and providing structured, defensible findings to clients.
  • For IP Advisors: Enables rapid FTO landscape mapping across scaffolds, R-groups, formulations, and method-of-use claims, reducing the risk of errors that could waste months of R&D investment.
  • For Strategy Consulting: Facilitates smarter portfolio allocation by identifying risks and opportunities earlier, helping organizations prioritize resources across the pipeline and maximize overall portfolio value.
  • Institutional Knowledge: Ensures insights generated from individual programs benefit the entire organization, turning one-off analyses into compounding institutional memory over time.

Security, Privacy, and Compliance

  • Enterprise-Grade Security: The platform includes encryption of data in transit and at rest, robust access controls, and full auditability built into the infrastructure.
  • Data Privacy: Customer data remains fully owned by the customer. Internal documents and experimental data are never used to train models or shared outside the customer's environment.
  • Compliance Certifications: Coincidence Labs maintains SOC 2, GDPR, and ISO compliance, with authenticated access and encrypted data handling as standard.
  • Dedicated Support: A team of drug discovery experts and machine learning scientists provides dedicated onboarding and responsive ongoing support to ensure customer success.

Coincidence Labs is trusted by leading pharma organizations, CROs, and IP advisors seeking to reduce costly late-stage failures, accelerate key program milestones, and build a more intelligent, evidence-driven approach to drug discovery and development.

AI-generated · replace with your own

Software attributed to Misogi Labs

  • Coincidence Labs AI PlatformView

Edit all with premium access

What you can manage

Every part of your profile.

Your company page and every software page attached to it. Nothing is held back — a premium profile includes all of it.

Accuracy

Your own descriptions

Replace the AI-generated summary with your own words — for your company and for every product you list.

Your own descriptions
The description editor in the profile admin panel

Discovery

Classification & search

List your software under up to three domains and subdomains, and appear in search as a company, not only as a product.

Classification & search
Software classified under three domains, and a company shown in search results

Evidence

Case studies

Published outcomes with images and links to the full write-up. Add as many as you need, edit them anytime.

Case studies
A two-column grid of case studies on a company profile

Product

Image gallery

Screenshots of the actual interface, in a gallery visitors can open full-size.

Image gallery
An image gallery of product screenshots on a software profile

Next step

Call-to-action

A dedicated block that sends visitors where you want them — a demo, a trial, or a contact form.

Call-to-action
A call-to-action block at the bottom of a software profile

And more:

Cover imageTeam membersClient & partner logosEmbedded videosDocuments & downloadsFAQSocial linksdofollow link to your siteControl over which products are listed
The full list

Basic listing vs premium profile

There are no tiers. Everything below is included with a premium profile, across your company page and every software page attached to it.

Software descriptions

Basic

AI-generated

Premium

You write them
Software classification

Basic

Limited & auto-inferred

Premium

Extended & defined by you
Company description

Basic

AI-generated

Premium

You write it
Company featured in search results

Basic

Not shown

Premium

Featured at the top
Backlink to your site

Basic

nofollow

Premium

dofollow
Links & socials

Basic

Basic

Premium

Full control
Call-to-action

Basic

Premium

Case studies section

Basic

Premium

Documents section

Basic

Premium

Videos section

Basic

Premium

Image gallery

Basic

Premium

Client/Partner logos

Basic

Premium

Team section

Basic

Premium

FAQ section

Basic

Premium

Cover image

Basic

Premium

Control over which products are listed

Basic

Premium

How it works

Three steps away.

01

You reach out

Fill in the form below with a few details about your company.

02

We talk

A short call or an email thread, whichever you prefer. We answer your questions and agree on the details.

03

You get access

We set up your login. From there you can edit everything and publish when you are ready.

Get in touch

Ready to claim the Misogi Labs profile?

Send a short note and we will get back to you.